Post-Stroke Cognitive Impairment and Dementia | Circulation Research
Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Laboratory Diagnosis of Creutzfeldt–Jakob Disease | NEJM
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports
Blood Pressure and Risks of Cognitive Impairment and Dementia | Hypertension
A microRNA signature that correlates with cognition and is a target against cognitive decline | EMBO Molecular Medicine
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression | Radiology: Artificial Intelligence
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
Evaluation of Suspected Dementia | AAFP
Initial Evaluation of the Patient with Suspected Dementia | AAFP
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect
Rapidly progressive dementias — aetiologies, diagnosis and management | Nature Reviews Neurology
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text
C-reactive protein and risk of cognitive decline: The REGARDS study | PLOS ONE
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - ScienceDirect
A Clinical Approach to Mild Cognitive Impairment | American Journal of Psychiatry
The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter
The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics
Vascular cognitive impairment | Nature Reviews Disease Primers
PDF) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease | Rosanna Squitti - Academia.edu
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment - eBioMedicine
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience
Recommended laboratory tests for patients suspected of dementia | Download Table
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
